AstraZeneca has withdrawn its COVID-19 vaccine from the market globally due to a decline in demand, but social media posts misleadingly linked the decision to the company admitting a rare risk of dangerous blood clots associated with the vaccine.
The post Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine appeared first on The Atlanta Voice.
